Doximity, Inc. DOCS
Set alert
32.76 USD -0.87 -2.59%
At close · Oct 30
32.76 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
32.49 Day range 33.89
18.01 52-week range 66.95
- YTD
- -26.02%
- 1 year
- -50.23%
- Open
- 33.48
- Prev close
- 33.63
- Mkt cap
- 5.84B
- Vol
- 2.20M
- Avg vol
- 4.44M
- EPS
- 0.85
- P/E
- 38.54
- Div yield
- 0.00%
More statistics
- Low
- 32.49
- High
- 33.89
- Forward P/E
- 21.09
- Beta
- 1.22
- Short ratio
- 2.84
- Inst. own
- 103.11%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 28.16
- 200-d avg
- 25.59
- 1y target
- 31.11
1Y chart
Events in this range
- Nov 6, 2025Earnings: 0.45; estimate 0.3787; surprise 18.83%
- Feb 5, 2026Earnings: 0.46; estimate 0.44; surprise 4.55%
- May 13, 2026Earnings: 0.26; estimate 0.28; surprise -7.14%
- Aug 6, 2026Earnings: 0.29; estimate 0.303; surprise -4.29%
- Aug 7, 2026Rating: JP Morgan · Neutral → Neutral
- Aug 10, 2026Downgrade: Wells Fargo · Equal-Weight → Underweight
- Aug 13, 2026Rating: Truist Securities · Hold → Hold
- Aug 21, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Sep 8, 2026Downgrade: Freedom Capital Markets · Buy → Hold
- Sep 29, 2026Rating: Evercore ISI Group · In-Line → In-Line
Signals (46)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 2026 | 2 days ago |
| RSI: Overbought | Oct 27, 2026 | 5 days ago |
| RSI: Overbought | Oct 20, 2026 | 1 week ago |
| RSI: Overbought | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 4, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 21, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 21, 2026 | 3 months ago |
| SMA: Bullish | Jul 9, 2026 | 3 months ago |
| SMA: Bearish | Jul 8, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 1, 2026 | 5 months ago |
| MACD: Sell Signal | May 14, 2026 | 5 months ago |
| RSI: Oversold | May 14, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 17, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 9, 2026 | 6 months ago |
| RSI: Oversold | Apr 7, 2026 | 6 months ago |
| RSI: Oversold | Apr 1, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 25, 2026 | 8 months ago |
| RSI: Oversold | Jan 29, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 27, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 15, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 15, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 11, 2025 | 10 months ago |
| RSI: Oversold | Dec 5, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| RSI: Oversold | Nov 7, 2025 | 11 months ago |
| SMA: Bearish | Nov 6, 2025 | 12 months ago |
Financial health
Altman Z-Score
22.87 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
A4 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 4
- P/E 2
- P/B 2
Valuation
P/E 22.2×
FY 2019 5y median 48.8× FY 2026
P/S 6.8×
FY 2019 5y median 14.9× FY 2026
P/B 4.6×
FY 2019 5y median 6.5× FY 2026
P/FCF 13.7×
FY 2019 5y median 36.1× FY 2026
EV/EBITDA 15.7×
FY 2019 5y median 42.6× FY 2026
EV/Sales 6.4×
FY 2019 5y median 14.6× FY 2026
FCF Yield 7.3%
FY 2019 5y median 2.8% FY 2026
Profitability
Gross Margin 89.1%
FY 2019 5y median 89.1% FY 2026
Operating Margin 33.3%
FY 2019 5y median 33.3% FY 2026
Net Margin 30.4%
FY 2019 5y median 31.0% FY 2026
ROE 20.6%
FY 2019 5y median 17.6% FY 2026
ROIC 17.4%
FY 2019 5y median 14.0% FY 2026
ROA 17.4%
FY 2019 5y median 15.6% FY 2026
Growth (YoY)
Revenue 13.1%
FY 2019 FY 2026
Operating Income -5.7%
FY 2019 FY 2026
EPS (diluted) -11.7%
FY 2019 FY 2026
Free Cash Flow 19.0%
FY 2019 FY 2026
Financial Health
Current Ratio 6.1×
FY 2019 5y median 7.0× FY 2026
Quick Ratio 6.1×
FY 2019 5y median 7.0× FY 2026
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2026
Net Debt / EBITDA -0.8×
FY 2019 5y median -0.8× FY 2026
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2026
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-03-31